SEMA3E and asthma: Given the potential of Sema3E as a therapeutic target for allergic HDM asthma [14,15], we sought to investigate the role of Sema3E in type 2-low asthma using preclinical models and to compare the effects of Sema3E deficiency in this model with those observed in the type 2-high asthma phenotype.